[Anticoagulation for HIT II: When should it be used therapeutically and when as prophylaxis?].
Greinacher
A
A
Institut für Immunologie und Transfusionsmedizin, Klinikum der Ernst-Moritz-Arndt-Universität, Greifswald, Germany.
D000925:Anticoagulants / Q000009:adverse effects / Q000627:therapeutic use*; D006493:Heparin / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D013921:Thrombocytopenia / Q000139:chemically induced* / Q000503:physiopathology / Q000517:prevention & control
D000925:Anticoagulants; D006493:Heparin